Kaydan Wealth Management, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History
Kaydan Wealth Management, Inc.
- $282 Billion
- Q2 2024
A detailed history of Kaydan Wealth Management, Inc. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Kaydan Wealth Management, Inc. holds 188,075 shares of DNA stock, worth $1.57 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
188,075
Previous 188,075
-0.0%
Holding current value
$1.57 Million
Previous $218 Million
71.18%
% of portfolio
0.02%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding DNA
# of Institutions
341Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.19 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.16 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.12 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$582 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$350 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.7B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...